Sanbox:Kamal: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) |
||
(36 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
[[File:Subtrochanteric-neck-of-femur-fracture.jpg|400px|thumb|left|xray showing femur fracture [https://radiopaedia.org/cases/spiral-fracture-of-femur source:Case courtesy of Dr Andrew Dixon, Radiopaedia.org, rID: 25704]]] | |||
[[File:Subtrochanteric-neck-of-femur-fracture.jpg|400px|thumb|left|xray showing femur fracture [https://radiopaedia.org/cases/spiral-fracture-of-femur source:Case courtesy of Dr Andrew Dixon, Radiopaedia.org, rID: 25704 ]]] | |||
<br style="clear:left" /> | <br style="clear:left" /> | ||
Line 47: | Line 10: | ||
[[File:Tibial fracture.jpg|400px|thumb|left|X-Ray showing Tibial Fracture [https://radiopaedia.org/cases/proximal-tibia-fracture source:Case courtesy of MD PhD gasssss, Radiopaedia.org, rID: 13768]]] | [[File:Tibial fracture.jpg|400px|thumb|left|X-Ray showing Tibial Fracture [https://radiopaedia.org/cases/proximal-tibia-fracture source:Case courtesy of MD PhD gasssss, Radiopaedia.org, rID: 13768]]] | ||
<br style="clear:left" />==References== | <br style="clear:left" />==References== | ||
==Differentiating NHL== | |||
{| | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constitutional symptoms | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Rash | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Abdominal pain | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Diarrhea | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mass | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | |||
|- | |||
! rowspan="12" align="center" style="background:#4479BA; color: #FFFFFF;" + |T cell lymphoma | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor T-cell lymphoblastic leukemia/lymphoma<ref name="pmid28892922">{{cite journal| author=Shelly D, Gujral S| title=Early T-Cell Precursor Acute Lymphoblastic Leukaemia/Lymphoma: Immunohistochemical Evaluation of Four Lymph Node Biopsies. | journal=J Clin Diagn Res | year= 2017 | volume= 11 | issue= 7 | pages= EL01-EL02 | pmid=28892922 | doi=10.7860/JCDR/2017/29352.10164 | pmc=5583929 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28892922 }}</ref><ref name="pmid26276771">{{cite journal| author=You MJ, Medeiros LJ, Hsi ED| title=T-lymphoblastic leukemia/lymphoma. | journal=Am J Clin Pathol | year= 2015 | volume= 144 | issue= 3 | pages= 411-22 | pmid=26276771 | doi=10.1309/AJCPMF03LVSBLHPJ | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26276771 }}</ref> | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Precursor T-cell Lymphomas | |||
| align="center" style="background:#F5F5F5;" + | | |||
* [[Fever]] | |||
* [[Fatigue]] | |||
* [[Weight loss]] | |||
* [[Night sweats]] | |||
* [[Skin rash]] | |||
* [[Chest pain]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* CD3 | |||
* CD7 | |||
* TDT | |||
| align="center" style="background:#F5F5F5;" + | | |||
** Blast-like cells with scant cytoplasm, convoluted nuclei, fine chromatin, indistinct nucleoli, | |||
*** Some lymphoblasts have cytoplasmic pseudopods | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* males in their teens to early twenties | |||
* lymphadenopathy in cervical, supraclavicular, axillary ,and mediastinum | |||
* In most patients the mediastinal mass is anterior; associated with pleural effusions. Can produce such complications as superior vena cava syndrome, tracheal obstruction, and pericardial effusions | |||
|- | |||
! colspan="2" |T-cell granular lymphocytic<ref name="Rose2004">{{cite journal|last1=Rose|first1=M. G.|title=T-Cell Large Granular Lymphocyte Leukemia and Related Disorders|journal=The Oncologist|volume=9|issue=3|year=2004|pages=247–258|issn=1083-7159|doi=10.1634/theoncologist.9-3-247}}</ref><ref name="pmid22800517">{{cite journal| author=Liu EB, Chen HS, Zhang PH, Li ZQ, Sun Q, Yang QY et al.| title=[Hematopathologic features of T-cell large granular lymphocytic leukemia]. | journal=Zhonghua Bing Li Xue Za Zhi | year= 2012 | volume= 41 | issue= 4 | pages= 229-33 | pmid=22800517 | doi=10.3760/cma.j.issn.0529-5807.2012.04.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22800517 }}</ref><ref name="pmid15958859">{{cite journal| author=Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A| title=Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. | journal=Am J Surg Pathol | year= 2005 | volume= 29 | issue= 7 | pages= 935-41 | pmid=15958859 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15958859 }}</ref> | |||
! | |||
* clonal proliferation of CD8 T cells | |||
* Constant immune stimulation | |||
* Absence of homeostatic apoptosis | |||
! | |||
* Fatigue | |||
* Lymphadenopathy | |||
* Fever | |||
* Enlarged liver and/or spleen | |||
* Frequent infections | |||
* Night sweats | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
* CD8 | |||
* CD57 | |||
* '''TCRαβ''' | |||
* CD3 | |||
* CD16 | |||
* Granzyme b | |||
* TIA1 | |||
!Medium / large lymphocytes with abundant cytoplasm having azurophilic granules | |||
! | |||
! | |||
|- | |||
! colspan="2" |T-cell prolymphocytic leukemia<ref name="pmid23382603">{{cite journal| author=Graham RL, Cooper B, Krause JR| title=T-cell prolymphocytic leukemia. | journal=Proc (Bayl Univ Med Cent) | year= 2013 | volume= 26 | issue= 1 | pages= 19-21 | pmid=23382603 | doi= | pmc=3523759 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23382603 }}</ref> | |||
! | |||
* Abnormal proliferation of mature T cells (post thymic) | |||
! | |||
* [[Fever]] | |||
* [[Fatigue]] | |||
* [[Weight loss]] | |||
* [[Night sweats]] | |||
* [[Skin rash]] | |||
* Hepatomegaly | |||
* Splenomegaly | |||
* Lymphadenopathy | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
* CD2 | |||
* CD3 | |||
* CD4 | |||
* CD5 | |||
* CD7 | |||
* CD56 | |||
* TCL1 | |||
! | |||
** lymphocytes with abundant basophilic, nongranular cytoplasm, atypical nucleus | |||
** cytoplasmic protrusions (blebs) | |||
! | |||
! | |||
|- | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Adult T-cell leukemia|Adult T cell leukemia/lymphoma]]<ref name="pmid18042693">{{cite journal |vauthors=Matutes E |title=Adult T-cell leukaemia/lymphoma |journal=J. Clin. Pathol. |volume=60 |issue=12 |pages=1373–7 |year=2007 |pmid=18042693 |pmc=2095573 |doi=10.1136/jcp.2007.052456 |url=}}</ref><ref name="pmid180426932">Matutes E (2007) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18042693 Adult T-cell leukaemia/lymphoma.] ''J Clin Pathol'' 60 (12):1373-7. [http://dx.doi.org/10.1136/jcp.2007.052456 DOI:10.1136/jcp.2007.052456] PMID: [http://pubmed.gov/18042693 18042693]</ref><ref name="pmid1751370">{{cite journal| author=Shimoyama M| title=Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). | journal=Br J Haematol | year= 1991 | volume= 79 | issue= 3 | pages= 428-37 | pmid=1751370 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1751370 }}</ref> | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
* Human T-lymphotrophic virus 1 infection | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Hepatospleanomagaly | |||
* Hypercalcemia | |||
* Skin lesions | |||
* Lytic bone lesions | |||
* Elevated LDH | |||
* T-cell deficiency leading immunodeficiency causing opportunistic infection | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Adult T-cell leukemia cells are typically [[CD2]], [[CD4]], [[CD5]], and [[CD8]] positive | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Charecterstic leukemia cells with sharp [[nuclear]] indentations and a prominent [[nucleoli]] | |||
* "Cloverleaf" or "flower" cells | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |Hypercalcemia | |||
|- | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Anaplastic large cell lymphoma]]<ref name="Al-AhmadMaertens2017">{{cite journal|last1=Al-Ahmad|first1=Selma|last2=Maertens|first2=Vincent|last3=Libeer|first3=Christophe|last4=Schelfhout|first4=Vera|last5=Vanhoenacker|first5=Filip|last6=Boeckx|first6=Nancy|last7=Vandevenne|first7=Marleen|title=The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature|journal=Acta Clinica Belgica|volume=72|issue=6|year=2017|pages=454–460|issn=1784-3286|doi=10.1080/17843286.2017.1312057}}</ref><ref name="pmid25197351">{{cite journal| author=Yu L, Yan LL, Yang SJ| title=Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature. | journal=Int J Clin Exp Pathol | year= 2014 | volume= 7 | issue= 8 | pages= 4806-16 | pmid=25197351 | doi= | pmc=4152041 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25197351 }}</ref><ref name="pmid28652989">{{cite journal| author=de Campos FPF, Zerbini MCN, Felipe-Silva A, Simões AB, Lovisolo SM, da Fonseca LG et al.| title=Unusual clinical presentation of anaplastic large cell lymphoma. | journal=Autops Case Rep | year= 2014 | volume= 4 | issue= 1 | pages= 21-27 | pmid=28652989 | doi=10.4322/acr.2014.004 | pmc=5470561 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28652989 }}</ref><ref name="pmid17965727">{{cite journal |author=Watanabe M, Ogawa Y, Itoh K |title=Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma |journal=Lab. Invest. |volume=88 |issue=1 |pages=48–57 |date=January 2008 |pmid=17965727 |doi=10.1038/labinvest.3700696|display-authors=etal}}</ref> | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
** [[Fever]] | |||
** [[Weight loss]] | |||
** [[Night sweats]] | |||
** Skin rash | |||
** Chest pain | |||
** [[Abdominal pain]] | |||
** [[Bone pain]] | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Strongly immunoreactive for [[CD30]], Anaplastic lymphoma kinase (ALK), EMA, and [[vimentin]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
* | |||
* Nucleoli tend to be more prominent | |||
* The cytoplasm may be either [[basophilic]] or [[eosinophilic]] and the cell might have many nuclei with dispersed or clumped [[chromatin]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Cutaneous T-cell lymphoma | |||
! align="center" style="background:#DCDCDC;" + |[[Mycosis fungoides]] / [[Sézary syndrome]]<ref name="FossGirardi2017">{{cite journal|last1=Foss|first1=Francine M.|last2=Girardi|first2=Michael|title=Mycosis Fungoides and Sezary Syndrome|journal=Hematology/Oncology Clinics of North America|volume=31|issue=2|year=2017|pages=297–315|issn=08898588|doi=10.1016/j.hoc.2016.11.008}}</ref><ref name="CampbellClark2010">{{cite journal|last1=Campbell|first1=J. J.|last2=Clark|first2=R. A.|last3=Watanabe|first3=R.|last4=Kupper|first4=T. S.|title=Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors|journal=Blood|volume=116|issue=5|year=2010|pages=767–771|issn=0006-4971|doi=10.1182/blood-2009-11-251926}}</ref><ref name="VonderheidBernengo2002">{{cite journal|last1=Vonderheid|first1=Eric C.|last2=Bernengo|first2=Maria Grazia|last3=Burg|first3=Günter|last4=Duvic|first4=Madeleine|last5=Heald|first5=Peter|last6=Laroche|first6=Liliane|last7=Olsen|first7=Elise|last8=Pittelkow|first8=Mark|last9=Russell-Jones|first9=Robin|last10=Takigawa|first10=Masahiro|last11=Willemze|first11=Rein|title=Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas|journal=Journal of the American Academy of Dermatology|volume=46|issue=1|year=2002|pages=95–106|issn=01909622|doi=10.1067/mjd.2002.118538}}</ref> | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) an<nowiki/>d [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | |||
* It is understood that cutaneous t cell lymphoma (maycosis fungoides, Sezary sydrome ) is the result of malignant T cell that derived from a mature CD41 CD45RO1 memory T cells. | |||
| align="left" style="background:#F5F5F5;" + | | |||
* [[Weight loss]] | |||
* [[Lymphadenopathy]] | |||
* [[Malaise]] and [[fatigue]] | |||
* [[Anemia]] | |||
* May progress to [[Sezary syndrome]] | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Cutaneous manifestations | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |Beta F1+, [[CD2]]-/+, [[CD3]]+, [[CD3]]- ([[CD4]]-positive variant), [[CD4]]+ ([[CD4]]-positive variant), [[CD4]]-, [[CD5]]-, [[CD7]]+/-, [[CD8]]+, [[CD8]]- ([[CD4]]-positive variant), [[Granzyme B|Granzyme B+]], and [[perforin]]+ | |||
| align="center" style="background:#F5F5F5;" + | | |||
:* polymorphous inflammatory infiltrate in the dermis that contains small numbers of frankly atypical [[lymphoid]] cells | |||
:* These cells may line up individually along the epidermal basal layer | |||
:* The presence of spongiosis is highly suggestive of mycosis fungoides | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* [[Epidermis (skin)|Epidermal]] [[atrophy]] or poikiloderma | |||
* Generalized [[itching]]([[pruritus]]) | |||
* [[Pain]] in the affected area of the skin. | |||
* [[Insomnia]] | |||
* Red ([[erythematous]]) patches scattered over the [[skin]] of the [[trunk]] and the [[extremities]] | |||
|- | |||
! rowspan="6" align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma | |||
! align="center" style="background:#DCDCDC;" + |[[Subcutaneous panniculitis-like T-cell lymphoma]]<ref name="seer.cancer.gov">Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016</ref><ref name="seer.cancer.gov2">Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016</ref><ref name="pmid191959752">{{cite journal| author=Parveen Z, Thompson K| title=Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. | journal=Arch Pathol Lab Med | year= 2009 | volume= 133 | issue= 2 | pages= 303-8 | pmid=19195975 | doi=10.1043/1543-2165-133.2.303 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19195975 }}</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
** [[Fever]] | |||
** [[Chills]] | |||
** [[Weight loss]] | |||
** [[Night sweats]] | |||
** [[Myalgias]] | |||
** Painless swellings on extremities and trunk | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Positive: BetaF1; [[CD8]]; [[CD30]]; [[CLA]]; T-cell intracellular antigen (T1A1); and [[perforin]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
* atypical lymphoid cells | |||
* [[fat necrosis]] | |||
* [[karyorrhexis]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |[[Hepatosplenic T cell lymphoma|Hepatosplenic T-cell lymphoma]]<ref name="pmid28058028">{{cite journal| author=van de Meeberg MM, Derikx LA, Sinnige HA, Nooijen P, Schipper DL, Nissen LH| title=Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy. | journal=World J Gastroenterol | year= 2016 | volume= 22 | issue= 47 | pages= 10465-10470 | pmid=28058028 | doi=10.3748/wjg.v22.i47.10465 | pmc=5175260 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28058028 }}</ref><ref name="ShiWang2015">{{cite journal|last1=Shi|first1=Yang|last2=Wang|first2=Endi|title=Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer–Cell Neoplasms|journal=Archives of Pathology & Laboratory Medicine|volume=139|issue=9|year=2015|pages=1173–1180|issn=0003-9985|doi=10.5858/arpa.2014-0079-RS}}</ref><ref name="pmid22379294">{{cite journal| author=Alsohaibani FI, Abdulla MA, Fagih MM| title=Hepatosplenic T-cell lymphoma. | journal=Indian J Hematol Blood Transfus | year= 2011 | volume= 27 | issue= 1 | pages= 39-42 | pmid=22379294 | doi=10.1007/s12288-010-0051-1 | pmc=3102508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22379294 }}</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
* Inflammatory bowel disease | |||
** Organ transplant patients (reciever) | |||
** Immunosuppresent medications | |||
** Thiopurines | |||
** Infliximab | |||
** Cyclophosphamide | |||
** Vincristine | |||
** Doxorubicin | |||
| align="center" style="background:#F5F5F5;" + | | |||
* [[Fever]] | |||
* [[Fatigue]] | |||
* [[Weight loss]] | |||
* [[Night sweats]] | |||
* [[Skin rash]] | |||
* [[Chest pain]] | |||
* [[Abdominal pain]] | |||
* [[Bone pain]] | |||
* Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* CD2, CD3, CD7, CD16 , CD56 or CD57, TIA1, Granzyme m, Fas ligand, | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Intermediate sized tumor cells with clear cytoplasm, oval nuclei, slightly dispersed condensed chromatin, inconspicuous nucleoli | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |[[Enteropathy-associated T-cell lymphoma|Enteropathy-type intestinal T-cell lymphoma]]<ref name="DelabieHolte2011">{{cite journal|last1=Delabie|first1=J.|last2=Holte|first2=H.|last3=Vose|first3=J. M.|last4=Ullrich|first4=F.|last5=Jaffe|first5=E. S.|last6=Savage|first6=K. J.|last7=Connors|first7=J. M.|last8=Rimsza|first8=L.|last9=Harris|first9=N. L.|last10=Muller-Hermelink|first10=K.|last11=Rudiger|first11=T.|last12=Coiffier|first12=B.|last13=Gascoyne|first13=R. D.|last14=Berger|first14=F.|last15=Tobinai|first15=K.|last16=Au|first16=W. Y.|last17=Liang|first17=R.|last18=Montserrat|first18=E.|last19=Hochberg|first19=E. P.|last20=Pileri|first20=S.|last21=Federico|first21=M.|last22=Nathwani|first22=B.|last23=Armitage|first23=J. O.|last24=Weisenburger|first24=D. D.|title=Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project|journal=Blood|volume=118|issue=1|year=2011|pages=148–155|issn=0006-4971|doi=10.1182/blood-2011-02-335216}}</ref><ref name="pmid22943012">{{cite journal |vauthors=Bautista-Quach MA, Ake CD, Chen M, Wang J |title=Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features |journal=J Gastrointest Oncol |volume=3 |issue=3 |pages=209–25 |date=September 2012 |pmid=22943012 |pmc=3418529 |doi=10.3978/j.issn.2078-6891.2012.024 |url=}}</ref><ref name="cancer.gov">Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 26, 2016</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
** [[Fever]] | |||
** [[Weight loss]] | |||
** [[Night sweats]] | |||
** [[Diarrhea]] | |||
** [[Skin rash]] | |||
** [[Chest pain]] | |||
** [[Abdominal pain]] | |||
** [[Bone pain]] | |||
** Painless swelling in the neck, [[axilla]], [[groin]], [[thorax]], and [[abdomen]] | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |[[CD3]]+, [[CD4]]-, [[CD5]]-, [[CD7]]+, [[CD30]]+, [[CD56]]+, [[CD103]]+, [[CD8]]+/-, and TCR beta+/- | |||
| align="center" style="background:#F5F5F5;" + | | |||
** lymphomatous infiltrate with neoplastic large cells | |||
** May have pleomorphic, multinucleated cells | |||
** Adjacent mucosa shows villous atrophy, crypt hyperplasia, increased inflammatory cells | |||
** lymphocytosis | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Extranodal T-cell lymphoma, nasal type<ref name="Hindawi">Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016</ref><ref name="cancer.gov2">Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016</ref><ref name="Hindawi2">Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 18, 2016</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
** [[Fever]] | |||
** [[Weight loss]] | |||
** [[Night sweats]] | |||
** Protrusion of eye | |||
** Swelling of the face | |||
** Discharge from the nose | |||
** Nose bleeds | |||
** Blockage of the nasal passages | |||
** Skin rash | |||
** Chest pain | |||
** [[Abdominal pain]] | |||
** [[Bone pain]] | |||
** Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Cytoplasmic [[CD3]] epsilon, Granzyme B, perforin, [[CD2]], [[CD56]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
* medium sized tumor cells and polymorphic infiltrate of non-neoplastic inflammatory cells | |||
* lymphoma cells may be admixed with a polymorphic infiltrate of non-neoplastic inflammatory cells | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Angioimmunoblastic T-cell lymphoma<ref name="who1">{{cite book |last=Swerdlow |first=S.H. |last2=Campo |first2=E. |last3=Harris |first3=N.L. |last4=Jaffe |first4=E.S. |last5=Pileri |first5=S.A. |last6=Stein |first6=H. |last7=Thiele |first7=J. |last8=Vardiman |first8=J.W |chapter=11 Mature T- and NK-cell neoplasms: Angioimmunoblastic T-cell lymphoma |title=WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues |edition=4th |series=IARC WHO Classification of Tumours |volume=2 |publisher=IARC |year=2008 |isbn=9283224310 |url=http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4002&content=1}}</ref><ref name="quin1">[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10524524&query_hl=30&itool=pubmed_ExternalLink] Quintanilla-Martinez L, Fend F, Moguel LR, Spilove L, Beaty MW, Kingma DW, Raffeld M, Jaffe ES. "Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection." '''Am J Surg Pathol'''. 1999 Oct;23(10):1233-40. PMID: 10524524</ref><ref name="seer">Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
* [[fever]], [[weight loss]], skin rash, [[night sweats]], [[edema]], chest pain, [[abdominal pain]], [[bone pain]], [[fatigue]], [[dark urine]], [[shortness of breath]], [[chronic pain]], swelling of joints and painless swelling in the neck, axilla, groin, thorax, and abdomen | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
* [[CD2]], [[CD3]], [[CD4]], [[CD5]], [[CD10]], [[CD20]], and focal positivity for [[CXCL13]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
* leukocytic infiltrate, represented mostly by elongated cells with marked artifactual changes | |||
* Hyperplastic [[germinal centers]] and [[Reed-Sternberg cells]] | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma, unspecified<ref name="pmid22760778">{{cite journal |vauthors=Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P |title=Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters |journal=Blood |volume=120 |issue=7 |pages=1466–9 |date=August 2012 |pmid=22760778 |doi=10.1182/blood-2012-02-408542 |url=}}</ref><ref name="JhaGupta2017">{{cite journal|last1=Jha|first1=KunalKishor|last2=Gupta|first2=SureshK|last3=Saluja|first3=Harpreet|last4=Subedi|first4=Nuwadatta|title=Peripheral T-cell lymphoma, not otherwise specified|journal=Journal of Family Medicine and Primary Care|volume=6|issue=2|year=2017|pages=427|issn=2249-4863|doi=10.4103/jfmpc.jfmpc_323_16}}</ref> | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
** Fatigue | |||
** Lymphadenopathy (swollen ) | |||
** Thirst | |||
** Nausea and vomiting | |||
** Fever | |||
** Skin and bone abnormalities | |||
** Enlarged liver and/or spleen | |||
** Frequent infections | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
** CD2, CD3, TCR '''β F1;''' variable CD4, CD5 and CD7 | |||
*** Occasional CD56 and cytotoxic granule expression | |||
| align="center" style="background:#F5F5F5;" + | | |||
** Clear cytoplasm, resemble Reed-Sternberg cells, with irregular, pleomorphic, hyperchromatic or nuclei | |||
** A lot of mitotic figures; very broad cytologic spectrum | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|} | |||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 20:00, 23 January 2019
==References==
Differentiating NHL
Category | Disease | Etiology | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | Immunochemistry | Histopathology | Gold standard | Associated findings | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T cell lymphoma | Precursor T-cell lymphoblastic leukemia/lymphoma[1][2] |
|
|
|
| ||||||||
T-cell granular lymphocytic[3][4][5] |
|
|
|
Medium / large lymphocytes with abundant cytoplasm having azurophilic granules | |||||||||
T-cell prolymphocytic leukemia[6] |
|
|
|
|
|||||||||
Adult T cell leukemia/lymphoma[7][8][9] |
|
|
+ | Hypercalcemia | |||||||||
Anaplastic large cell lymphoma[10][11][12][13] |
|
|
+ | + |
|
Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome[14][15][16] |
|
|
+ | + |
|
Beta F1+, CD2-/+, CD3+, CD3- (CD4-positive variant), CD4+ (CD4-positive variant), CD4-, CD5-, CD7+/-, CD8+, CD8- (CD4-positive variant), Granzyme B+, and perforin+ |
|
| ||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma[17][18][19] |
|
|
|
|||||||||
Hepatosplenic T-cell lymphoma[20][21][22] |
|
|
+ | + |
|
|
|||||||
Enteropathy-type intestinal T-cell lymphoma[23][24][25] |
|
|
+ | + | CD3+, CD4-, CD5-, CD7+, CD30+, CD56+, CD103+, CD8+/-, and TCR beta+/- |
|
|||||||
Extranodal T-cell lymphoma, nasal type[26][27][28] |
|
|
|
||||||||||
Angioimmunoblastic T-cell lymphoma[29][30][31] |
|
|
|
||||||||||
Peripheral T-cell lymphoma, unspecified[32][33] |
|
|
|
|
- ↑ Shelly D, Gujral S (2017). "Early T-Cell Precursor Acute Lymphoblastic Leukaemia/Lymphoma: Immunohistochemical Evaluation of Four Lymph Node Biopsies". J Clin Diagn Res. 11 (7): EL01–EL02. doi:10.7860/JCDR/2017/29352.10164. PMC 5583929. PMID 28892922.
- ↑ You MJ, Medeiros LJ, Hsi ED (2015). "T-lymphoblastic leukemia/lymphoma". Am J Clin Pathol. 144 (3): 411–22. doi:10.1309/AJCPMF03LVSBLHPJ. PMID 26276771.
- ↑ Rose, M. G. (2004). "T-Cell Large Granular Lymphocyte Leukemia and Related Disorders". The Oncologist. 9 (3): 247–258. doi:10.1634/theoncologist.9-3-247. ISSN 1083-7159.
- ↑ Liu EB, Chen HS, Zhang PH, Li ZQ, Sun Q, Yang QY; et al. (2012). "[Hematopathologic features of T-cell large granular lymphocytic leukemia]". Zhonghua Bing Li Xue Za Zhi. 41 (4): 229–33. doi:10.3760/cma.j.issn.0529-5807.2012.04.004. PMID 22800517.
- ↑ Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A (2005). "Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review". Am J Surg Pathol. 29 (7): 935–41. PMID 15958859.
- ↑ Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
- ↑ Matutes E (2007). "Adult T-cell leukaemia/lymphoma". J. Clin. Pathol. 60 (12): 1373–7. doi:10.1136/jcp.2007.052456. PMC 2095573. PMID 18042693.
- ↑ Matutes E (2007) Adult T-cell leukaemia/lymphoma. J Clin Pathol 60 (12):1373-7. DOI:10.1136/jcp.2007.052456 PMID: 18042693
- ↑ Shimoyama M (1991). "Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)". Br J Haematol. 79 (3): 428–37. PMID 1751370.
- ↑ Al-Ahmad, Selma; Maertens, Vincent; Libeer, Christophe; Schelfhout, Vera; Vanhoenacker, Filip; Boeckx, Nancy; Vandevenne, Marleen (2017). "The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature". Acta Clinica Belgica. 72 (6): 454–460. doi:10.1080/17843286.2017.1312057. ISSN 1784-3286.
- ↑ Yu L, Yan LL, Yang SJ (2014). "Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature". Int J Clin Exp Pathol. 7 (8): 4806–16. PMC 4152041. PMID 25197351.
- ↑ de Campos FPF, Zerbini MCN, Felipe-Silva A, Simões AB, Lovisolo SM, da Fonseca LG; et al. (2014). "Unusual clinical presentation of anaplastic large cell lymphoma". Autops Case Rep. 4 (1): 21–27. doi:10.4322/acr.2014.004. PMC 5470561. PMID 28652989.
- ↑ Watanabe M, Ogawa Y, Itoh K; et al. (January 2008). "Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma". Lab. Invest. 88 (1): 48–57. doi:10.1038/labinvest.3700696. PMID 17965727.
- ↑ Foss, Francine M.; Girardi, Michael (2017). "Mycosis Fungoides and Sezary Syndrome". Hematology/Oncology Clinics of North America. 31 (2): 297–315. doi:10.1016/j.hoc.2016.11.008. ISSN 0889-8588.
- ↑ Campbell, J. J.; Clark, R. A.; Watanabe, R.; Kupper, T. S. (2010). "Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors". Blood. 116 (5): 767–771. doi:10.1182/blood-2009-11-251926. ISSN 0006-4971.
- ↑ Vonderheid, Eric C.; Bernengo, Maria Grazia; Burg, Günter; Duvic, Madeleine; Heald, Peter; Laroche, Liliane; Olsen, Elise; Pittelkow, Mark; Russell-Jones, Robin; Takigawa, Masahiro; Willemze, Rein (2002). "Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas". Journal of the American Academy of Dermatology. 46 (1): 95–106. doi:10.1067/mjd.2002.118538. ISSN 0190-9622.
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016
- ↑ Parveen Z, Thompson K (2009). "Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas". Arch Pathol Lab Med. 133 (2): 303–8. doi:10.1043/1543-2165-133.2.303. PMID 19195975.
- ↑ van de Meeberg MM, Derikx LA, Sinnige HA, Nooijen P, Schipper DL, Nissen LH (2016). "Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy". World J Gastroenterol. 22 (47): 10465–10470. doi:10.3748/wjg.v22.i47.10465. PMC 5175260. PMID 28058028.
- ↑ Shi, Yang; Wang, Endi (2015). "Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer–Cell Neoplasms". Archives of Pathology & Laboratory Medicine. 139 (9): 1173–1180. doi:10.5858/arpa.2014-0079-RS. ISSN 0003-9985.
- ↑ Alsohaibani FI, Abdulla MA, Fagih MM (2011). "Hepatosplenic T-cell lymphoma". Indian J Hematol Blood Transfus. 27 (1): 39–42. doi:10.1007/s12288-010-0051-1. PMC 3102508. PMID 22379294.
- ↑ Delabie, J.; Holte, H.; Vose, J. M.; Ullrich, F.; Jaffe, E. S.; Savage, K. J.; Connors, J. M.; Rimsza, L.; Harris, N. L.; Muller-Hermelink, K.; Rudiger, T.; Coiffier, B.; Gascoyne, R. D.; Berger, F.; Tobinai, K.; Au, W. Y.; Liang, R.; Montserrat, E.; Hochberg, E. P.; Pileri, S.; Federico, M.; Nathwani, B.; Armitage, J. O.; Weisenburger, D. D. (2011). "Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project". Blood. 118 (1): 148–155. doi:10.1182/blood-2011-02-335216. ISSN 0006-4971.
- ↑ Bautista-Quach MA, Ake CD, Chen M, Wang J (September 2012). "Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features". J Gastrointest Oncol. 3 (3): 209–25. doi:10.3978/j.issn.2078-6891.2012.024. PMC 3418529. PMID 22943012.
- ↑ Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 26, 2016
- ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016
- ↑ Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016
- ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 18, 2016
- ↑ Swerdlow, S.H.; Campo, E.; Harris, N.L.; Jaffe, E.S.; Pileri, S.A.; Stein, H.; Thiele, J.; Vardiman, J.W (2008). "11 Mature T- and NK-cell neoplasms: Angioimmunoblastic T-cell lymphoma". WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC WHO Classification of Tumours. 2 (4th ed.). IARC. ISBN 9283224310.
- ↑ [1] Quintanilla-Martinez L, Fend F, Moguel LR, Spilove L, Beaty MW, Kingma DW, Raffeld M, Jaffe ES. "Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection." Am J Surg Pathol. 1999 Oct;23(10):1233-40. PMID: 10524524
- ↑ Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015
- ↑ Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P (August 2012). "Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters". Blood. 120 (7): 1466–9. doi:10.1182/blood-2012-02-408542. PMID 22760778.
- ↑ Jha, KunalKishor; Gupta, SureshK; Saluja, Harpreet; Subedi, Nuwadatta (2017). "Peripheral T-cell lymphoma, not otherwise specified". Journal of Family Medicine and Primary Care. 6 (2): 427. doi:10.4103/jfmpc.jfmpc_323_16. ISSN 2249-4863.